Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 361

1,4-α-D-glucan branching enzyme preparation

Intended Use: Use as an enzyme to catalyze the production of modified food starch ingredients including highly branched cyclic dextrins and enzymatically-synthesized glycogen
Basis: Scientific procedures
Notifier: Takashi Kuriki
Ezaki Glico Co., Ltd.
Notifier Address: 4-6-5, Utajima Nishioyogogawa
Osaka
JAPAN
Date of filing: Nov 18, 2010
GRAS Notice (releasable information): GRN 361 (in PDF)
Date of closure: Jan 31, 2011
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice
-
-